Literature DB >> 21351239

Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.

Mylène Sebagh1, Daniel Azoulay, Bruno Roche, Emir Hoti, Vincent Karam, Elina Teicher, Laurence Bonhomme-Faivre, Faouzi Saliba, Jean-Charles Duclos-Vallée, Didier Samuel.   

Abstract

After liver transplantation (LT), hepatic veno-occlusive disease (VOD), which is also known as sinusoidal obstruction syndrome (SOS), has been reported initially in relation to azathioprine use and subsequently in relation to acute rejection (AR). Isolated veno-occlusive disease (iVOD)/SOS raises some questions about its significance and especially its treatment. From the post-LT biopsy samples of 1364 patients (2000-2008), 31 patients with index biopsy samples showing VOD/SOS (2.3%) were identified. After a review of the index biopsy samples and previous biopsy samples, those patients not exposed to azathioprine therapy were subdivided into 2 groups according to the absence or presence of AR. Fifteen of the 31 patients had no previous evidence of AR, whereas 16 experienced episodes of AR (before or concurrently with VOD). The 2 groups were similar in terms of demographic and clinical data and the range of histological centrilobular changes. AR episodes were characterized by an endothelial predilection. iVOD/SOS occurred later than acute rejection-related veno-occlusive disease (AR-VOD)/SOS (mean times of 65 and 4.4 months, respectively, P = 0.0098). There was a tendency for iVOD/SOS to progress less frequently to chronic rejection in comparison with AR-VOD/SOS (3/15 versus 9/15, P = 0.06). The histological resolution of iVOD/SOS was significantly more frequent in patients who benefited from increased immunosuppression in comparison with those who did not (5/7 versus 2/8, P = 0.05). When the groups were considered together, the same result was obtained (14/18 versus 4/12, P = 0.024). In conclusion, despite a constant overall prevalence of VOD/SOS, the proportion of iVOD/SOS has increased. The histological resolution of iVOD/SOS after increase in immunosuppression suggests an immune-mediated origin. Better optimization of immunosuppression may be a curative treatment.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21351239     DOI: 10.1002/lt.22282

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation.

Authors:  Tian Shen; Xiao-Wen Feng; Lei Geng; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 2.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

3.  Biliary obstruction following transjugular intrahepatic portosystemic shunt placement in a patient after liver transplantation: A case report.

Authors:  Peter Macinga; Darina Gogova; Jan Raupach; Jana Jarosova; Libor Janousek; Eva Honsova; Pavel Taimr; Julius Spicak; Jiri Novotny; Jan Peregrin; Tomas Hucl
Journal:  World J Hepatol       Date:  2022-05-27

4.  Inferior vena cava stenosis-induced sinusoidal obstructive syndrome after living donor liver transplantation.

Authors:  Batsaikhan Bat-Erdene; Sergelen Orgoi; Erdene Sandag; Ulzii-Orshikh Namkhai; Bat-Ireedui Badarch; Batsaikhan Batsuuri
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

5.  Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study.

Authors:  Aránzazu Caballero-Marcos; Isabel Peligros; Judith Pérez-Rojas; Isabel Campos-Varela; Jordi Colmenero; Miguel Ángel Gómez-Bravo; Iago Justo; Alejandra Otero; Esther Molina-Pérez; Luisa González-Diéguez; Carme Baliellas; Mario Romero-Cristobal; Victoria Aguilera; Lluís Castells; Alba Díaz; Luis Miguel Marín-Gómez; Carmelo Loinaz; Rafael Bañares; Magdalena Salcedo
Journal:  Liver Transpl       Date:  2022-04-28       Impact factor: 6.112

Review 6.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.

Authors:  Tae Beom Lee; Kwangho Yang; Hyo Jung Ko; Jae Ryong Shim; Byung Hyun Choi; Jung Hee Lee; Je Ho Ryu
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.